Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26310146 | 0.90 | GPR84 (0.45) | FAAHGPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL10621540 | 0.90 | GPR84 (0.45) | FAAHGPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL7128921 | 0.90 | GPR84 (0.45) | FAAHGPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL9387572 | 0.90 | GPR84 (0.45) | FAAHGPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL31348960 | 0.90 | GPR84 (0.45) | FAAHGPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL8534953 | 0.88 | CA2 (0.46) | CTSKFAAHGPR84FFAR1MAPT | |
| SCHEMBL12310033 | 0.88 | CA2 (0.46) | CTSKFAAHGPR84FFAR1MAPT | |
| SCHEMBL11990796 | 0.86 | CTSK (0.46) | CTSKFAAHGPR84FFAR1MAPT | |
| SCHEMBL14712354 | 0.86 | CTSK (0.46) | CTSKFAAHGPR84FFAR1MAPT | |
| SCHEMBL5017987 | 0.85 | PRKCA (0.46) | PRKCAPRKCDCTSKCA1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117924134-A | Method for preparing di (2-ethylhexyl) peroxydicarbonate by one-step method and application thereof | 鄂尔多斯市瀚博科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-109265384-B | Method for preparing di (2-ethylhexyl) peroxydicarbonate | 南京工业大学 | 2021-02-12 | — | — | CN | claimed |
| EP-3666755-A1 | ONLINE FULL CONTINUOUS FLOW PRODUCTION PROCESS FOR DIRECTLY PREPARING ORGANIC PEROXIDE WITH HYDROGEN PEROXIDE AS RAW MATERIAL | Shanghai Hybrid-Chem Technologies (CN) | 2020-06-17 | — | — | EP | claimed |
| CN-117924134-A | Method for preparing di (2-ethylhexyl) peroxydicarbonate by one-step method and application thereof | 鄂尔多斯市瀚博科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-10947189-B2 | Online continuous flow process for the synthesis of organic peroxides using hydrogen peroxide as raw material | SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) | 2021-03-16 | — | — | US | disclosed |
| CN-109265384-B | Method for preparing di (2-ethylhexyl) peroxydicarbonate | 南京工业大学 | 2021-02-12 | — | — | CN | disclosed |
| CN-111302941-A | Method for preparing chloroformic acid-2-ethylhexyl ester | 江苏扬农化工集团有限公司 | 2020-06-19 | — | — | CN | disclosed |
| EP-3666755-A1 | ONLINE FULL CONTINUOUS FLOW PRODUCTION PROCESS FOR DIRECTLY PREPARING ORGANIC PEROXIDE WITH HYDROGEN PEROXIDE AS RAW MATERIAL | Shanghai Hybrid-Chem Technologies (CN) | 2020-06-17 | — | — | EP | disclosed |
| US-20200172478-A1 | ONLINE CONTINUOUS FLOW PROCESS FOR THE SYNTHESIS OF ORGANIC PEROXIDES USING HYDROGEN PEROXIDE AS RAW MATERIAL | SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) | 2020-06-04 | — | — | US | disclosed |
| EP-1940811-B1 | HETEROCYCLIC COMPOUNDS WITH CARBOXYL ISOSTERE GROUPS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER IP GMBH (DE) | 2014-02-26 | — | — | EP | disclosed |
| CN-101605784-B | Aza-bridged-ring compound | ASTELLAS PHARMA INC JP | 2013-04-10 | — | — | CN | disclosed |
| US-7998988-B2 | Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders | BAYER SCHERING PHARMA AKTIENGELLSCHAFT (DE) | 2011-08-16 | — | — | US | disclosed |
| US-7998988-B2 | Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders | BAYER SCHERING PHARMA AKTIENGELLSCHAFT (DE) | 2011-08-16 | — | — | US | disclosed |
| CN-101605784-A | Aza-bridged-ring compound | ASTELLAS PHARMA INC (JP) | 2009-12-16 | — | — | CN | disclosed |
| US-20090227640-A1 | Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases | BAYER HEALTHCARE AG (DE) | 2009-09-10 | — | — | US | disclosed |
| US-20090227640-A1 | Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases | BAYER HEALTHCARE AG (DE) | 2009-09-10 | — | — | US | disclosed |
| WO-2007045366-A1 | HETEROCYCLIC COMPOUNDS WITH CARBOXYL ISOSTERE GROUPS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER HEALTHCARE AG (DE) | 2007-04-26 | — | — | WO | disclosed |
| US-6762303-B2 | OXIDIZING A DIHYDROPYRIDINE COMPOUND IN THE PRESENCE OF NITROUS ACID OR A NITRITE OR A BASE AND HYDROGEN PEROXIDE SOLUTION | FUJI PHOTO FILM CO., LTD. (JP) | 2004-07-13 | — | — | US | disclosed |
| US-20020065420-A1 | Method for producing pyridine compounds | FUJIFILM CORPORATION (JP) | 2002-05-30 | — | — | US | disclosed |
| EP-0332761-A2 | Single-functional and mixtures of multifunctional oligomeric performance additive compositions, and their use | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1989-09-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227640-A1 | Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases | TNNI3, PC, TNNT2 | PRKCA 518/4885PRKCD 770/4885CTSK 1194/4885 |
| US-10947189-B2 | Online continuous flow process for the synthesis of organic peroxides using hydrogen peroxide as raw material | PPOX, HAO2, AOX1 | PRKCA 1604/4885PRKCD 2260/4885CTSK 1143/4885 |
| US-20020065420-A1 | Method for producing pyridine compounds | NOX1, NOX5, NOX4 | PRKCA 2304/4885PRKCD 3146/4885CTSK 3547/4885 |
| US-20200172478-A1 | ONLINE CONTINUOUS FLOW PROCESS FOR THE SYNTHESIS OF ORGANIC PEROXIDES USING HYDROGEN PEROXIDE AS RAW MATERIAL | PPOX, HAO2, AOX1 | PRKCA 1604/4885PRKCD 2260/4885CTSK 1143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.